Barriers to collaboration

Throughout this book, we have described the barriers to more effective supply chains. We have also described many of the tools and techniques that address this barrier. One initiative addresses both the cultural and technical barriers to collaboration among supply chain partners. The initiative is collaborative planning, forecasting, and replenishment (CPFR). CPFR requires a business relationship between partners and has taken root in the retail industry. Collaboration strives to better match demand and supply, improve inventory management practices, and capitalize on new systems through sharing. CPFR is primarily a link between retailers and their manufacturer suppliers. It is expected that the concepts will expand to other industries. 

What are the pohcies, practices and interactions that promote collaboration What are the policies, practices and interactions that reinforce barriers to collaboration ... 

C3Fire.org. Bridging cultural barriers to collaborative decision making in on site operations coordination centers. http //www.c3fire.org/c3fire/examples/ examples-bcb.en.shtml. Accessed 16 Apr 2015... 

National Tests. It is clearly possible to remove the technical barrier to trade represented by different national fire test procedures, by providing a facility for a manufacturer to conduct the relevant tests once and within his home country, with a guarantee of acceptability of the results by all Member States. This requires laboratories to equip themselves with all the necessary equipment and for an extensive interlaboratory collaboration and calibration procedure to be introduced, which would ensure mutual acceptance of test results. 

In this breakout session the group addressed issues regarding interdisciplinary educational approaches. Some barriers to interdisciplinary collaboration are ... 

Identify and resolve barriers to rapid discovery turnover We believe the following may be key issues for facilitation of collaboration between groups ... 

It is important to underscore the depth of the institutional obstacles facing these scientist-activists. As noted in the previous section, their promotional texts cited numerous barriers to interdisciplinary collaboration. The scientific status of genetics added further to the problem. While fast gaining prominence in American life science, genetics circa 1970 was far from the powerful disci-... 

Because of increased difficulty in getting a new drug on an MCO s formulary, it is now common for pharmaceutical companies to collaborate with managed care decision makers in round table or advisory board meetings. These discussions, which normally occur before product launch or as early as phases II and III of clinical development, are helpful in determining reimbursement status and identifying potential barriers and restrictions that may be placed on the product, once approved. 

---